Nasal Spray Flu Vaccine Not Recommended for Upcoming Flu Season
The Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) voted that the live attenuated influenza vaccine (LAIV), also known as the nasal spray flu vaccine, should not be used during the upcoming 2016-2017 flu season.
However, ACIP continues to recommend annual flu vaccination with either the inactivated influenza vaccine (IIV) or recombinant influenza vaccine (RIV) for everyone 6 months of age and older.
Why Did ACIP Vote This Way?
The ACIP vote is based on data that showed poor or relatively lower effectiveness of LAIV from 2013 through 2016. LAIV, which is sold as FluMist Quadrivalent, is currently the only non-injection-based flu vaccine available on the market.
How Do I Spread the Word to Patients?
To help start conversations with patients, the AAAAI has a new article describing that while the nasal spray influenza vaccine is not recommended for the upcoming flu season, they still need their flu shot. Access the article in English and Spanish using the links below. You are invited to share the links directly with patients or on your social media.
- Get an Employment and Human Resources Legal Primer
- Get Ready for the 2018 Joint Congress: Abstract and NEW Case Report Submission Opening Soon
- Introducing “Eczema and Contact Dermatitis in the Allergy/Immunology Practice”
- An Opportunity to Join JACI: Apply for the New Web and Social Media Editor Position
- Have a $240,000 Idea?
- The Best Funding for Research is Free
- CMS Approves AAAAI QCDR
- Access Key Sessions You Missed at the 2017 Annual Meeting
- Looking for the Next Step in Your Career?